BindingDB logo
myBDB logout

BDBM50523606 CHEMBL4461166

SMILES: OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1

InChI Key: InChIKey=LVXCTBHTIRUVQQ-SAABIXHNSA-N

Data: 1 KI  4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50523606   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
1,3-beta-glucan synthase component GLS2


(Saccharomyces cerevisiae)
BDBM50523606
PNG
(CHEMBL4461166)
Show SMILES OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1 |r,wU:7.10,wD:4.3,(75.44,-57.01,;74.68,-55.67,;73.14,-55.65,;75.46,-54.34,;74.71,-53,;75.49,-51.67,;74.72,-50.32,;73.19,-50.33,;72.41,-51.65,;73.16,-52.98,;72.43,-48.99,;70.89,-48.99,;70.11,-50.31,;68.58,-50.31,;67.82,-48.97,;68.58,-47.64,;70.12,-47.65,;66.29,-48.97,;65.51,-47.63,;63.97,-47.64,;63.21,-48.97,;63.97,-50.3,;65.51,-50.3,;61.67,-48.97,;60.77,-47.72,;59.29,-48.19,;57.96,-47.43,;57.95,-45.89,;56.63,-48.2,;56.63,-49.74,;57.96,-50.52,;59.29,-49.74,;60.76,-50.22,)|
Show InChI InChI=1S/C25H29FN4O3/c26-20-2-1-3-21-24(20)29-25(28-21)17-6-9-22(27-15-17)30-12-10-19(11-13-30)33-18-7-4-16(5-8-18)14-23(31)32/h1-3,6,9,15-16,18-19H,4-5,7-8,10-14H2,(H,28,29)(H,31,32)/t16-,18-
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
1.07E+4n/an/an/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human ERG


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Sterol O-acyltransferase 1


(Homo sapiens (Human))
BDBM50523606
PNG
(CHEMBL4461166)
Show SMILES OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1 |r,wU:7.10,wD:4.3,(75.44,-57.01,;74.68,-55.67,;73.14,-55.65,;75.46,-54.34,;74.71,-53,;75.49,-51.67,;74.72,-50.32,;73.19,-50.33,;72.41,-51.65,;73.16,-52.98,;72.43,-48.99,;70.89,-48.99,;70.11,-50.31,;68.58,-50.31,;67.82,-48.97,;68.58,-47.64,;70.12,-47.65,;66.29,-48.97,;65.51,-47.63,;63.97,-47.64,;63.21,-48.97,;63.97,-50.3,;65.51,-50.3,;61.67,-48.97,;60.77,-47.72,;59.29,-48.19,;57.96,-47.43,;57.95,-45.89,;56.63,-48.2,;56.63,-49.74,;57.96,-50.52,;59.29,-49.74,;60.76,-50.22,)|
Show InChI InChI=1S/C25H29FN4O3/c26-20-2-1-3-21-24(20)29-25(28-21)17-6-9-22(27-15-17)30-12-10-19(11-13-30)33-18-7-4-16(5-8-18)14-23(31)32/h1-3,6,9,15-16,18-19H,4-5,7-8,10-14H2,(H,28,29)(H,31,32)/t16-,18-
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a>1.00E+4n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human ACAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))
BDBM50523606
PNG
(CHEMBL4461166)
Show SMILES OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1 |r,wU:7.10,wD:4.3,(75.44,-57.01,;74.68,-55.67,;73.14,-55.65,;75.46,-54.34,;74.71,-53,;75.49,-51.67,;74.72,-50.32,;73.19,-50.33,;72.41,-51.65,;73.16,-52.98,;72.43,-48.99,;70.89,-48.99,;70.11,-50.31,;68.58,-50.31,;67.82,-48.97,;68.58,-47.64,;70.12,-47.65,;66.29,-48.97,;65.51,-47.63,;63.97,-47.64,;63.21,-48.97,;63.97,-50.3,;65.51,-50.3,;61.67,-48.97,;60.77,-47.72,;59.29,-48.19,;57.96,-47.43,;57.95,-45.89,;56.63,-48.2,;56.63,-49.74,;57.96,-50.52,;59.29,-49.74,;60.76,-50.22,)|
Show InChI InChI=1S/C25H29FN4O3/c26-20-2-1-3-21-24(20)29-25(28-21)17-6-9-22(27-15-17)30-12-10-19(11-13-30)33-18-7-4-16(5-8-18)14-23(31)32/h1-3,6,9,15-16,18-19H,4-5,7-8,10-14H2,(H,28,29)(H,31,32)/t16-,18-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 910n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Activity against human A2AR assessed as inhibition of cAMP accumulation by cAMP functional assay


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Diacylglycerol O-acyltransferase 1


(Mus musculus (mouse))
BDBM50523606
PNG
(CHEMBL4461166)
Show SMILES OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1 |r,wU:7.10,wD:4.3,(75.44,-57.01,;74.68,-55.67,;73.14,-55.65,;75.46,-54.34,;74.71,-53,;75.49,-51.67,;74.72,-50.32,;73.19,-50.33,;72.41,-51.65,;73.16,-52.98,;72.43,-48.99,;70.89,-48.99,;70.11,-50.31,;68.58,-50.31,;67.82,-48.97,;68.58,-47.64,;70.12,-47.65,;66.29,-48.97,;65.51,-47.63,;63.97,-47.64,;63.21,-48.97,;63.97,-50.3,;65.51,-50.3,;61.67,-48.97,;60.77,-47.72,;59.29,-48.19,;57.96,-47.43,;57.95,-45.89,;56.63,-48.2,;56.63,-49.74,;57.96,-50.52,;59.29,-49.74,;60.76,-50.22,)|
Show InChI InChI=1S/C25H29FN4O3/c26-20-2-1-3-21-24(20)29-25(28-21)17-6-9-22(27-15-17)30-12-10-19(11-13-30)33-18-7-4-16(5-8-18)14-23(31)32/h1-3,6,9,15-16,18-19H,4-5,7-8,10-14H2,(H,28,29)(H,31,32)/t16-,18-
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 21n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of mouse DGAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Diacylglycerol O-acyltransferase 1


(Homo sapiens (Human))
BDBM50523606
PNG
(CHEMBL4461166)
Show SMILES OC(=O)C[C@H]1CC[C@@H](CC1)OC1CCN(CC1)c1ccc(cn1)-c1nc2c(F)cccc2[nH]1 |r,wU:7.10,wD:4.3,(75.44,-57.01,;74.68,-55.67,;73.14,-55.65,;75.46,-54.34,;74.71,-53,;75.49,-51.67,;74.72,-50.32,;73.19,-50.33,;72.41,-51.65,;73.16,-52.98,;72.43,-48.99,;70.89,-48.99,;70.11,-50.31,;68.58,-50.31,;67.82,-48.97,;68.58,-47.64,;70.12,-47.65,;66.29,-48.97,;65.51,-47.63,;63.97,-47.64,;63.21,-48.97,;63.97,-50.3,;65.51,-50.3,;61.67,-48.97,;60.77,-47.72,;59.29,-48.19,;57.96,-47.43,;57.95,-45.89,;56.63,-48.2,;56.63,-49.74,;57.96,-50.52,;59.29,-49.74,;60.76,-50.22,)|
Show InChI InChI=1S/C25H29FN4O3/c26-20-2-1-3-21-24(20)29-25(28-21)17-6-9-22(27-15-17)30-12-10-19(11-13-30)33-18-7-4-16(5-8-18)14-23(31)32/h1-3,6,9,15-16,18-19H,4-5,7-8,10-14H2,(H,28,29)(H,31,32)/t16-,18-
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 8n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human DGAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair